05.11.2021 | Published by Endpoints News

bit.bio adds $100M+ investments and board of directors

On the left Sir Gregory Paul Winter CBE FRS FMedSci, Nobel Prize-winning British molecular biologist and bit.bio's board member, right Dr Mark Kotter Founder and CEO bit.bio 

bit.bio CEO Dr Mark Kotter was interviewed by END Points on bit.bio's $103m Series B fundraise and board appointments.

“I’m not going to say this is going to be easy. It’s going to be super hard, but our advantage is that we’re not fighting a biology that is resisting, you know, scale up and consistency.”


 Mark Kotter
 Founder and CEO


Read the full Endpoints News article. 



Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs